Abstract
Inflammatory diseases of the central nervous system are severe processes with a wide range of pathogenetic disorders and lead to a gross deficiency in the nervous system or, in the worst cases, to the death of the patient. Acute inflammatory diseases of the central nervous system represent an extremely heterogeneous group of diseases and conditions in terms of clinical manifestations and prognosis, traditionally combined according to one of the main pathomorphological signs - primary demyelination.